5,425 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Teladoc (TDOC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates https://www.zacks.com/stock/news/2228928/teladoc-tdoc-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228928 Feb 20, 2024 - The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Community Health Systems (CYH) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2228925/compared-to-estimates-community-health-systems-cyh-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2228925 Feb 20, 2024 - Although the revenue and EPS for Community Health Systems (CYH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
National Health Investors (NHI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2228926/national-health-investors-nhi-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228926 Feb 20, 2024 - While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Toll Brothers (TOL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2228934/toll-brothers-tol-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228934 Feb 20, 2024 - Although the revenue and EPS for Toll Brothers (TOL) give a sense of how its business performed in the quarter ended January 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Globus Medical (GMED) Q4 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2228933/compared-to-estimates-globus-medical-gmed-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2228933 Feb 20, 2024 - The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
SolarEdge (SEDG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2228930/solaredge-sedg-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228930 Feb 20, 2024 - While the top- and bottom-line numbers for SolarEdge (SEDG) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About RingCentral (RNG) Q4 Earnings https://www.zacks.com/stock/news/2228932/here-s-what-key-metrics-tell-us-about-ringcentral-rng-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2228932 Feb 20, 2024 - While the top- and bottom-line numbers for RingCentral (RNG) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
NeoGenomics (NEO) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates https://www.zacks.com/stock/news/2228931/neogenomics-neo-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228931 Feb 20, 2024 - While the top- and bottom-line numbers for NeoGenomics (NEO) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates https://www.zacks.com/stock/news/2228929/abcellera-biologics-inc-abcl-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2228929 Feb 20, 2024 - Although the revenue and EPS for AbCellera Biologics Inc. (ABCL) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Select Water Solutions, Inc. (WTTR) Reports Q4 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2228935/select-water-solutions-inc-wttr-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2228935 Feb 20, 2024 - Although the revenue and EPS for Select Water Solutions, Inc. (WTTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
<<<Page 377>